ORLY 177.11 O'Reilly Automotive $ORLY Hit a 52 week high of

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
ORLY 177.11 O'Reilly Automotive $ORLY Hit a 52 week high of 178.12 Closing the day 11/04/14 at 177.11 +1.25 +0.71% With a day low of 175.01 and a total volume of 871,500.

ORLY Recent Posts: http://investorshangout.com/OReilly-Automotiv...RLY-55010/

ORLY O'Reilly Automotive Recent Headline News

Is O'Reilly Automotive (ORLY) a Great Growth Stock? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 7:32AM CDT
O'Reilly Automotive is a fast growing stock that is still seeing plenty of opportunities on the horizon and have double digit earnings growth prospect
ORLY: 177.11 (+1.25)

Auto Parts, Home Furnishing Spending Stays Strong
at Investor's Business Daily - Thu Oct 30, 11:58AM CDT
Spending on big-ticket goods like home furnishings, appliances and auto parts rose at a healthy clip over the past year, according to a report on fast-growing retail segments that Sageworks released Wednesday. The report was based on an analysis of...
RH: 78.36 (-1.85), AAP: 148.44 (+0.68), ORLY: 177.11 (+1.25), WSM: 64.33 (-0.63)

Quarterly Financial Results and Share Buyback Program Expansion - Research Reports on United Continental, Tractor Supply, Cabela's, CarMax and O'Reilly
PR Newswire - Tue Oct 28, 8:10AM CDT
Today, Analysts Review released its research reports regarding United Continental Holdings, Inc. (NYSE: UAL), Tractor Supply Company (NASDAQ: TSCO), Cabela's Incorporated (NYSE: CAB), CarMax Inc. (NYSE: KMX) and O'Reilly Automotive Inc. (NASDAQ: ORLY). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7491-100free.
KMX: 55.43 (-0.89), TSCO: 72.48 (-0.94), ORLY: 177.11 (+1.25), CAB: 46.60 (-1.16), UAL: 55.21 (+0.93)

O'Reilly Automotive (ORLY) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Mon Oct 27, 9:43AM CDT
The following O'Reilly Automotive (ORLY) conference call took place on October 23, 2014, 11:00 AM ET. This is a transcript of that earnings call:
ORLY: 177.11 (+1.25)

SmarTrend Watching for Potential Pullback in Shares of O'Reilly Automotive After 1.82% Gain
Comtex SmarTrend(R) - Fri Oct 24, 4:54PM CDT
O'Reilly Automotive (NASDAQ:ORLY) traded in a range yesterday that spanned from a low of $166.88 to a high of $170.89. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $169.13 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ORLY: 177.11 (+1.25)

Watch for O'Reilly Automotive to Potentially Pullback After Gaining 1.82% Yesterday
Comtex SmarTrend(R) - Fri Oct 24, 4:53PM CDT
O'Reilly Automotive (NASDAQ:ORLY) traded in a range yesterday that spanned from a low of $166.88 to a high of $170.89. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $169.13 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ORLY: 177.11 (+1.25)

Jim Cramer on the Markets: 10 Names That Ignited Thursday's Rally
at The Street - Fri Oct 24, 10:30AM CDT
I could have selected several others as well.
TSCO: 72.48 (-0.94), MMM: 155.05 (+1.75), DO: 33.50 (-1.22), NOW: 66.88 (+0.67), PH: 126.38 (-0.39), ORLY: 177.11 (+1.25), AAL: 42.70 (+0.70), CAT: 98.61 (-1.61), UNP: 115.28 (+0.02), CELG: 105.75 (-1.66)

Jim Cramer's 'Mad Money' Recap: 10 Stocks That Led the Bulls' Charge
at The Street - Thu Oct 23, 7:07PM CDT
The bulls crushed the bears today in hand-to-hand combat, and Cramer gives 10 reasons why.
MMM: 155.05 (+1.75), JAH: 64.79 (-0.60), AVT: 43.07 (+0.03), FB: 75.76 (+1.88), ORLY: 177.11 (+1.25), COV: 92.03 (-0.39), EW: 119.78 (-0.15), BA: 125.84 (-0.19), UAN: 11.93 (-0.15), CELG: 105.75 (-1.66), TSCO: 72.48 (-0.94), DO: 33.50 (-1.22), NOW: 66.88 (+0.67), PH: 126.38 (-0.39), BGS: 29.23 (+0.05), AAL: 42.70 (+0.70), CAT: 98.61 (-1.61), FTK: 21.16 (-1.14), UNP: 115.28 (+0.02)

Major Indexes Close Higher; Lannett Breaks Out
at Investor's Business Daily - Thu Oct 23, 3:16PM CDT
Stocks closed with a strong rebound Thursday, recouping Wednesday's losses and then some. The Nasdaq rallied 1.6%, the S&P 500 1.2% and the Dow Jones industrial average 1.3%. Thanks to upbeat quarterly earnings reports, Caterpillar (CAT) and 3M (MMM)...
LCI: 56.25 (-1.27), MMM: 155.05 (+1.75), SKX: 55.10 (-0.41), ORLY: 177.11 (+1.25), ALXN: 191.30 (+0.26), CAT: 98.61 (-1.61)

Nascent Rally Gains Traction; Caterpillar, 3M Boost Dow
at Investor's Business Daily - Thu Oct 23, 1:58PM CDT
Major averages showed broad gains and were near session highs with a little more than one hour remaining in Wednesday's session. The Nasdaq jumped 2.1% and the S&P 500 and Dow Jones industrial average gained 1.8% each. The Dow was helped by strong...
AMZN: 302.81 (-2.91), LCI: 56.25 (-1.27), MMM: 155.05 (+1.75), AAP: 148.44 (+0.68), ORLY: 177.11 (+1.25), CAT: 98.61 (-1.61), EPAM: 46.61 (-1.10), CERN: 63.48 (+0.22)

O'Reilly (ORLY) Tops Q3 Earnings on Operational Merit - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 9:10AM CDT
O'Reilly (ORLY) posted a 22% increase in earnings to $2.06 per share in the third quarter of 2014, surpassing the Zacks Consensus Estimate of $1.95.
KMX: 55.43 (-0.89), AAP: 148.44 (+0.68), PBY: 9.30 (-0.12), ORLY: 177.11 (+1.25)

Gabelli & Company's 38th Annual Automotive Aftermarket Symposium
Business Wire - Thu Oct 23, 6:00AM CDT
Gabelli & Company will host its 38th Annual Automotive Aftermarket Symposium on November 3-4 in Las Vegas, Nevada. This conference showcases a full spectrum of leading automotive companies, including aftermarket parts retailers, original equipment & aftermarket parts suppliers, publicly traded dealership groups, and medium & heavy duty truck manufacturers. Presentations, fireside chats, and one-on-one meetings will be held from 12:00 p.m. PST on Monday, November 3 through 5:00 p.m. PST on Tuesday, November 4. The event occurs in conjunction with the AAPEX & SEMA industry trade shows. Investors should contact their salesperson for more information or to register.
UNS.TO: 28.18 (-0.16), GPC: 97.83 (+0.69), LKQ: 28.18 (-0.61), GBL: 81.65 (-0.70), PAG: 44.90 (-0.25), REMY: 18.29 (-0.07), DCI: 41.57 (+0.04), RUSHA: 36.39 (-1.05), TEN: 51.61 (-0.91), PBY: 9.30 (-0.12), MNRO: 52.43 (+0.02), MPAA: 29.33 (-0.06), DAN: 19.93 (-0.27), NAV: 34.95 (-0.93), SUP: 18.47 (-0.71), LAD: 74.14 (-1.08), ALV: 91.69 (-0.12), ORLY: 177.11 (+1.25), TOWR: 23.76 (-0.39), CLC: 66.27 (-0.05), LEA: 90.84 (-0.95), FDML: 15.12 (-0.28), BWA: 55.71 (-1.36), SMP: 38.87 (-0.43), CTB: 32.36 (-0.04), AZO: 554.36 (+2.18), AN: 55.96 (-0.44)

O'Reilly Automotive, Inc. Reports Third Quarter 2014 Results
GlobeNewswire - Wed Oct 22, 4:11PM CDT
-- Third quarter comparable store sales increase of 6.2%
ORLY: 177.11 (+1.25)

ALB, VAR, TSCO, ORLY, EEFT, SFG Expected To Be Up After Next Earnings Releases
M2 - Wed Oct 22, 3:23AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Wednesday, October 22nd 2014 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and October earnings reports. ALBEMARLE CORPORATION (NYSE:ALB), Varian Medical Systems Inc (NYSE:VAR), Tractor Supply Co (NASDAQ:TSCO), O'Reilly Automotive Inc (NASDAQ:ORLY), Euronet Worldwide Inc (NASDAQ:EEFT), Stancorp Financial Group Inc (NYSE:SFG) are all expected to be Up After their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Up After earnings are released Wednesday:
TSCO: 72.48 (-0.94), SFG: 69.68 (+0.30), VAR: 84.31 (+0.55), ALB: 58.80 (+0.07), ORLY: 177.11 (+1.25), EEFT: 54.50 (+0.41)

Advance Auto: Are Merger Synergies Set To Kick In?
at Investor's Business Daily - Tue Oct 21, 5:24PM CDT
When auto-parts retail stocks like Advanced Auto Parts (AAP) start to do well, their rise sometimes unfurls a red flag. These stocks often excel when the economy is weak and consumers are under pressure. At such times, owners coddle their aging cars...
AZO: 554.36 (+2.18), AAP: 148.44 (+0.68), ORLY: 177.11 (+1.25)

Yahoo, Super Micro Rally After Hours
at Investor's Business Daily - Tue Oct 21, 4:03PM CDT
The stock market today rallied for a fourth straight session, extending its rebound. A heavy batch of earnings reports helped lift the market Tuesday. Better-than-expected quarterly results also helped Super Micro Computer (SMCI) and Yahoo (YHOO) to...
BIIB: 322.06 (+0.81), YHOO: 47.08 (+0.74), SMCI: 32.77 (+0.09), VMW: 83.54 (-0.73), LRCX: 79.34 (+0.20), SKX: 55.10 (-0.41), ORLY: 177.11 (+1.25), YELP: 60.10 (-1.22), PII: 149.74 (-0.67)

O'Reilly Automotive Set to Possibly Pullback After Yesterday's Rally of 1.89%
Comtex SmarTrend(R) - Mon Oct 20, 5:06PM CDT
O'Reilly Automotive (NASDAQ:ORLY) traded in a range yesterday that spanned from a low of $151.87 to a high of $155.23. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of $152.74 on volume of 958,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ORLY: 177.11 (+1.25)

Look for Shares of O'Reilly Automotive to Potentially Pullback after Yesterday's 1.89% Rise
Comtex SmarTrend(R) - Mon Oct 20, 5:05PM CDT
O'Reilly Automotive (NASDAQ:ORLY) traded in a range yesterday that spanned from a low of $151.87 to a high of $155.23. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of $152.74 on volume of 958,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ORLY: 177.11 (+1.25)

Is O'Reilly Automotive (ORLY) Likely to Miss on Q3 Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 20, 3:40PM CDT
O'Reilly Automotive Inc. (ORLY) is set to report its third-quarter 2014 results on Oct 22.
PCAR: 65.39 (unch), ORLY: 177.11 (+1.25), AXL: 19.76 (-0.07), MTOR: 11.41 (-0.01)

Standard Motor to Grow on Acquisitions, Brand Recognition - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 17, 4:50PM CDT
On Oct 10, 2014, we issued an updated research report on Standard Motor Products Inc. (SMP).
SMP: 38.87 (-0.43), AAP: 148.44 (+0.68), GPC: 97.83 (+0.69), ORLY: 177.11 (+1.25)

O'Reilly Automotive, Inc. (ORLY) Stock Research Links

ORLY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 446

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 56

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 333

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 38

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 90

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 104

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading

Top 5 Most Recently Viewed Articles

SOCi's AI Marketing: Leading G2's Summer 2026 Rankings

Updated Category News Views 12

AI's Rising Star in Enterprise Marketing Here's a tidbit worth chewing over your morning coffee: SOCi Inc., a name that's been buzzing in the enterprise circles, has nailed top spots in G2's Summer 2026 Report. We're talking about leading the charge in AI marketing and localized visibility, territories tough to crack unless you've got serious chops. In a world where...

Continue Reading
AI and the Future of Staffing: A Market Growth Story

Updated Category News Views 344

AI and the Future of Staffing: A Growth Story The staffing services market is on the verge of a major transformation, thanks in large part to advancements in Artificial Intelligence (AI). This evolution is projected to add an astounding USD 236.6 billion to the global staffing services market between 2024 and 2028. During this time, the market is expected to experience a...

Continue Reading
Optical Innovations Unite: OCC and Lightera's New Partnership

Updated Category News Views 317

Strategic Collaboration Between OCC and Lightera Optical Cable Corporation (NASDAQ: OCC) and Lightera, LLC are entering a significant partnership aimed at enhancing their product offerings primarily in the data center and enterprise sectors. This collaboration builds upon their long-term relationship, combining their strengths to create innovative optical connectivity...

Continue Reading
INFINOX Welcomes Artem Gonov as New Chief Technology Officer

Updated Category News Views 148

INFINOX Appoints Artem Gonov as Chief Technology Officer INFINOX, a globally recognized brokerage, has recently appointed Artem Gonov as its new Chief Technology Officer (CTO). This strategic move underlines the company's commitment to enhancing its technology landscape and providing exceptional platforms for its clients. Artem Gonov's Background and Expertise Mr. Gonov...

Continue Reading
George Medicines’ GMRx2 Sets New Standard for Hypertension Care

Updated Category News Views 126

George Medicines Introduces GMRx2 for Hypertension Management Recent findings published in The Lancet highlighted the promising results of a Phase III trial for GMRx2, a novel triple combination pill aimed at managing hypertension. Developed by George Medicines, this medication is making waves in the field of cardiovascular care as it demonstrates significant advancements...

Continue Reading